Medtronic hits more snags with SynchroMed II
This article was originally published in Clinica
Executive Summary
Medtronic has warned doctors worldwide of a potential defect with the batteries in a batch of its SynchromMed II implantable drug infusion pumps, which could lead to disruption in the patient's therapy.